登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 7810 条符合本次的查询结果， 用时 1.7379555 秒

7581. Avacopan for the Treatment of ANCA-Associated Vasculitis.

作者: David R W Jayne.;Peter A Merkel.;Thomas J Schall.;Pirow Bekker.; .
来源: N Engl J Med. 2021年384卷7期599-609页
The C5a receptor inhibitor avacopan is being studied for the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

7582. Correcting "Stolen Breaths". Reply.

作者: Rachel R Hardeman.;Eduardo M Medina.;Rhea W Boyd.
来源: N Engl J Med. 2021年384卷12期1178页

7583. Correcting "Stolen Breaths".

作者: Christine Walsh.
来源: N Engl J Med. 2021年384卷12期1177页

7584. Reform of Payment for Primary Care - From Evolution to Revolution.

作者: Allan H Goroll.;Ann C Greiner.;Stephen C Schoenbaum.
来源: N Engl J Med. 2021年384卷9期788-791页

7585. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.

作者: Judith Absalon.;Kenneth Koury.;William C Gruber.
来源: N Engl J Med. 2021年384卷16期1578页

7586. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

作者: Xiang Wang.
来源: N Engl J Med. 2021年384卷16期1577-1578页

7587. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

作者: Jean-Noel Vergnes.
来源: N Engl J Med. 2021年384卷16期1577页

7588. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

作者: Danuta M Skowronski.;Gaston De Serres.
来源: N Engl J Med. 2021年384卷16期1576-1577页

7589. Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.

作者: Siri R Kadire.;Robert M Wachter.;Nicole Lurie.
来源: N Engl J Med. 2021年384卷9期e28页

7590. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.

作者: Thomas Powles.;Jonathan E Rosenberg.;Guru P Sonpavde.;Yohann Loriot.;Ignacio Durán.;Jae-Lyun Lee.;Nobuaki Matsubara.;Christof Vulsteke.;Daniel Castellano.;Chunzhang Wu.;Mary Campbell.;Maria Matsangou.;Daniel P Petrylak.
来源: N Engl J Med. 2021年384卷12期1125-1135页
Patients with advanced urothelial carcinoma have poor overall survival after platinum-containing chemotherapy and programmed cell death protein 1 (PD-1) or programmed death ligand 1 (PD-L1) inhibitor treatment.

7591. Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.

作者: Lisa Rosenbaum.
来源: N Engl J Med. 2021年384卷14期1367-1371页

7592. Caring for the Caregivers - Covid-19 Vaccination for Essential Members of the Health Care Team.

作者: Meghan C Halley.;Christina Mangurian.
来源: N Engl J Med. 2021年384卷9期e33页

7593. Learning How to Die - Lessons from the Irish Wake.

作者: Rose M Olson.
来源: N Engl J Med. 2021年384卷6期494-495页

7594. A Shared Evaluation Platform for Medical Training.

作者: John F McConville.;James N Woodruff.
来源: N Engl J Med. 2021年384卷6期491-493页

7595. Heart-Shaped Lesion.

作者: Sami Karapolat.;Mustafa Sisman.
来源: N Engl J Med. 2021年384卷6期562页

7596. Evinacumab for Homozygous Familial Hypercholesterolemia. Reply.

作者: Frederick J Raal.;Daniel Gaudet.;Viktoria Gusarova.
来源: N Engl J Med. 2021年384卷6期e17页

7597. Evinacumab for Homozygous Familial Hypercholesterolemia.

作者: Hua-Guo Xu.
来源: N Engl J Med. 2021年384卷6期e17页

7598. Evinacumab for Homozygous Familial Hypercholesterolemia.

作者: Fei Luo.;Avash Das.;Zhenfei Fang.
来源: N Engl J Med. 2021年384卷6期e17页

7599. Evinacumab for Homozygous Familial Hypercholesterolemia.

作者: Mehmet Agirbasli.
来源: N Engl J Med. 2021年384卷6期e17页

7600. Endometrial Cancer. Reply.

作者: Karen H Lu.;Russell R Broaddus.
来源: N Engl J Med. 2021年384卷6期586页
共有 7810 条符合本次的查询结果， 用时 1.7379555 秒